Article Details
Retrieved on: 2024-07-12 18:41:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A twice-daily version of the drug, named danuglipron, was scrapped late in 2023, but the new drug is now advancing toward clinical trials in a ...
Article found on: kffhealthnews.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here